Trial Site Detail

 

Drug:
MEDI-573
Trial:
A Dose-Escalation Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-573 in Subjects With Advanced Solid Tumors
Conditions: Solid Tumors
Trial Status:
Ongoing, but not recruiting

 

Mayo Clinic, Rochester

     
Rochester , MN 55905
USA

 

Principal Investigator:
Paul Haluska, MD, PhD
Contact:
Janet Lensing 507-284-3137 lensing.janet@mayo.edu
Activation Status of this Site:
Closed
Notes about this Site:
Mayo Clinic, Rochester Website:
http://clinicaltrials.mayo.edu/dspSubthemes.cfm?theme_id=3

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.